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.2013.02.Abstract Objectives: To evaluate obesity effect on anesthetic and surgical outcome of patients of
varying BMI assigned for open abdominal surgery.
Patients and methods: Sixty patients were categorized according to WHO classiﬁcation of obesity
into three classes: class I (n= 30), class II (n= 18) and class III (n= 12). All patients underwent
open laparotomy under combined anesthesia using continuous remifentanil infusion and balanced
sevoﬂurane anesthesia. Hemodynamic variables, duration of surgery, intraoperative bleeding, fre-
quency of blood transfusion, recovery times and intraoperative anesthetic or surgical problems were
recorded. The occurrence of postoperative complications, admission to ICU, duration till 1st ambu-
lation, 1st oral intake, hospital stay period and rates of morbidity and mortality were recorded.
Results: Induction of anesthesia signiﬁcantly decreased arterial pressures and heart rate compared
both to preoperative and pre-induction measures. After extubation all parameters returned to pre-
operative levels. Mean operative time was signiﬁcantly longer and mean intraoperative blood loss
was signiﬁcantly more in patients of class III compared to those of class I and II. All recovery times
showed BMI dependence as all were signiﬁcantly prolonged in class II and III patients compared to
class I patients with signiﬁcantly shorter awakening and extubation times in class II patients than
class III patients. Mean time till 1st walk was signiﬁcantly longer in class III patients than class I
and II patients, but time till 1st oral intake was non-signiﬁcantly different. Sixteen patients developed
PO complications. Mean PO hospital stay was signiﬁcantly longer in class III patients compared to
class I and II patients with signiﬁcantly shorter duration in class II patients than those of class III.2857972.
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196 W. Ahmed Ibrahim, A. Abdalla MohamedConclusion: Obesity caused deleterious anesthetic and surgical effects with prolonged operative and
recovery times and more need for blood transfusion, ICU admission and prolonged hospital stay
duration. The used anesthetic regimen allowed controlled hypotension without compromising
patients’ general condition.
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Obesity is a condition of excessive body fat, an individual must
be considered obese when the amount of fat tissue is increased
to such an extent that physical and mental health are affected
and life expectancy reduced [1]. Obesity is a multisystem
chronic pro-inﬂammatory disorder associated with increased
morbidity and mortality. Adipocytes are far more than storage
vessels for lipids. They secrete a large number of physiologi-
cally active substances that lead to inﬂammation, vascular
and cardiac remodeling, airway inﬂammation, and altered
microvascular ﬂow patterns [2].
Body mass is an important determinant of respiratory func-
tion before and during anesthesia not only in morbidly but
also in moderately obese patients. These can manifest as re-
duced lung volume with increased atelectasis; derangements
in respiratory system, lung and chest wall compliance and in-
creased resistance; and moderate to severe hypoxaemia. These
physiological alterations are more marked in obese patients
with hypercapnic syndrome or obstructive sleep apnoea syn-
drome [3,4].
Anesthesiologists should be familiar not just with screening
tools for obstructive sleep apnea but also with obesity hypo-
ventilation syndrome, which is less well appreciated and carries
a signiﬁcant outcome disadvantage. Perioperative manage-
ment is challenging. It is centered around cardiorespiratory
and metabolic optimization, minimizing adverse effects of
both pain and systemic opioids, effective use of regional anes-
thesia, and an emphasis on mobilization and nutrition [5].
The current prospective study aimed to evaluate the impact
of obesity on anesthetic and surgical outcome of patients of
varying body mass index assigned for open abdominal surgery.
2. Patients and methods
The current study was conducted at Departments of Anesthe-
sia and General Surgery, Kasr El-Eniy University hospital
since June 2010 till August 2011. After approval of study pro-
tocol by the Local Ethical Committee and obtaining written
fully informed patients’ consent, 60 patients with BMIP
30 kg/m2 and assigned to undergo open major abdominal
surgeries were enrolled in the study.
Preoperative evaluation included clinical examination for
risk assessment, investigations and adjustment of associated
co-morbidities. All patients with medical diseases were contin-
ued postoperatively on the same lines of treatment applied pre-
operatively. All patients underwent determination of body
weight and height and calculation of body mass index accord-
ing to the equation: BMI =Wt (kg)/(Height in meter)2 [6]. Pa-
tients were categorized according to the World Health
Organization [7] classiﬁcation of obesity into: class I for a
BMI between 30 and 34.9 kg/m2, class II for a BMI between
35 and 39.9 kg/m2, and class III for a BMIP 40 kg/m2.The same anesthetic technique was applied for all patients.
Before induction, patients were pre-oxygenated and baseline
arterial blood pressures, heart rate (HR), respiratory rate
(RR) and arterial O2 saturation (PsaO2) were non-invasively
recorded and continuously monitored throughout theater
time. Anesthesia was induced with a bolus, in 120 s, of remif-
entanil in a dose of 1 lg/kg, followed by propofol 1.5 mg/kg
and cis-atracurium 0.15 mg/kg to facilitate orotracheal intuba-
tion. General anesthesia was maintained by balanced anesthe-
sia of 14 lg/kg/h remifentanil intravenous infusion and 1.24%
end-tidal sevoﬂurane in oxygen and air. Ventilation was con-
trolled and minute ventilation was adjusted to maintain end ti-
dal CO2 at 35 ± 5 mmHg. Intraoperative neuromuscular
block was produced with cis-atracurium. At the end of sur-
gery, atropine sulfate 0.02 mg/kg and neostigmine 0.04 mg/kg
were administered I.V for reversal of muscle relaxation and
the patient was extubated. Following extubation, patients were
maintained on supplemental O2 until being awake in the recov-
ery room. Duration of surgery and occurrence of intraopera-
tive anesthetic or surgical problems were recorded.
Major haemorrhage was deﬁned as calculated blood loss of
>1000 cc based on the difference between the preoperative
and postoperative packed cell volume (PCV), and was calcu-
lated as follows: estimated blood volume · (preoperative
PCV  postoperative PCV)/preoperative PCV and estimated
blood volume = booking weight (kg) · 85 [8].
Emergence times to awakening, i.e., opening eyes on verbal
command and orientation, i.e., correctly telling date, place,
and person were determined at 1-min intervals after discontin-
uation of the maintenance anesthetics. Times from discontinu-
ation of anesthesia until the patient was transferred to the
post-anesthesia care unit (PACU) and PACU times were also
recorded.
The occurrence of postoperative complications, postopera-
tive admission to ICU based upon concomitant diseases and
surgical requirements, the duration till ﬁrst ambulation, ﬁrst
oral intake and length of postoperative hospital stay and rates
of morbidity and mortality were recorded.3. Results
The study included 60 patients; 23 males and 37 females with
mean age of 38.5 ± 5.8; range: 26–48 years. There was non-
signiﬁcant (p> 0.05) difference between patients categorized
according to BMI as regards age and gender distribution.
Thirty patients (50%) were class I with mean BMI of
33.2 ± 1 kg/m2, 18 patients (30%) were class II with mean
BMI of 38.8 ± 0.8 kg/m2 and 12 patients (20%) were class
III with mean BMI of 43.4 ± 2.2 kg/m2. Only 14 patients
(23.3%) were free of associated co-morbidities, while 46 pa-
tients (76.7%) had multiple co-morbidities in varied distribu-
tion. Patients of class I had signiﬁcantly lower frequency of
Table 1 Patients’ enrollment data.
Total Class I Class II Class III
Number 60 30 (50%) 18 (30%) 12 (20%)
Age (years) 38.5 ± 5.8 (26–48) 38.6 ± 6.3 (26–48) 38 ± 6.3 (27–47) 39 ± 6.3 (27–47)
Gender
Males 23 (38.3%) 13 (43.3%) 7 (38.9%) 3 (25%)
Females 37 (61.7%) 17 (56.7%) 11 (61.1%) 9 (75%)
Anthropometric data
Weight (kg) 100.4 ± 10.1 (87–120) 92.7 ± 4.6 (87–107) 104.5 ± 7.3 (94–115) 113.3 ± 6.4 (103–120)
Height (cm) 165.2 ± 5.3 (155–178) 167.2 ± 4.2 (161–178) 164 ± 5.3 (155–171) 161.8 ± 6 (155–170)
BMI (kg/m2) 36.9 ± 4.3 (30.8–47.5) 33.2 ± 1 (30.8–34.9) 38.8 ± 0.8 (37.2–39.8) 43.4 ± 2.2 (40.5–47.5)
Associated co-morbidities
No 14 (23.3%) 10 (33.3%) 3 (16.7%)* 1 (8.3%)*,
Diabetes 17 (25%) 8 (26.6%) 5 (27.8%) 4 (33.3%)
Hypertension 13 (20%) 5 (16.7%) 5 (27.8%) 3 (25%)
COPD 9 (12.5%) 5 (16.7%) 2 (11%) 2 (16.7%)
Asthma 7 (10%) 2 (6.7%) 3 (16.7%) 2 (16.7%)
Indications of surgery
AAW hernias 14 (23.4%) 7 (23.3%) 5 (27.8%) 2 (16.7%)
Open cholecystectomy 8 (13.3%) 4 (13.3%) 2 (11%) 2 (16.7%)
Hysterectomy 5 (8.3%) 2 (6.7%) 1 (5.6%) 2 (16.7%)
Gastrectomy and bypass 11 (18.4%) 6 (20%) 3 (16.7%) 2 (16.7%)
Incisional hernia 8 (13.3%) 4 (13.3%) 3 (16.7%) 1 (8.3%)
Gastric sleeve 8 (13.3%) 4 (13.3%) 2 (11%) 2 (16.7%)
Colectomy 4 (6.7%) 2 (6.7%) 1 (5.6%) 1 (8.3%)
Exploration CBD 2 (3.3%) 1 (3.3%) 1 (5.6%) 0
Data are presented as mean ± SD and numbers; ranges and percentages are in parenthesis, BMI: body mass index, COPD: chronic obstructive
pulmonary disease, AAW: anterior abdominal wall, CBD: common bile duct,
* Signiﬁcant versus class I,
 Signiﬁcant versus class II.
Table 2 Hemodynamic changes occurred in studied patients throughout the duration of the procedure.
HR (beat/min) SAP (mmHg) DAP (mmHg) MAP (mmHg)
Preoperative 79.6 ± 4.2 119.2 ± 3.3 82.5 ± 5.1 94.7 ± 3.5
Before induction 80.7 ± 4.3 118.6 ± 2.8 81.9 ± 2.8 94.1 ± 3.1
After induction 72.8 ± 3.9* 104.7 ± 5* 79.4 ± 2.6* 87.8 ± 2.2*
After extubation 81 ± 4.3 116.5 ± 4.1 81.1 ± 3.8 92.9 ± 3.4
Data are presented as mean ± SD, HR: heart rate, SAP: systolic arterial pressure, DAP: diastolic artery pressure, MAP: mean arterial pressure,
* Signiﬁcant difference versus preoperative measures.
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p< 0.05) and class III (X2 = 7.781, p< 0.05) with non-signif-
icantly higher frequency of co-morbidities among patients of
class III compared to those of class II (X2 = 1.821,
p> 0.05). Twenty-two patients (36.7%) had hernias, 19 pa-
tients (31.7%) were assigned for bariatric surgeries and the
remaining patients (31.6%) had varied surgical indications
for laparotomy (Table 1).
All patients showed non-signiﬁcant (p> 0.05) difference of
hemodynamic measures estimated as baseline or before induc-
tion of anesthesia. Induction of anesthesia signiﬁcantly
(p< 0.05) decreased arterial pressures and HR compared both
to preoperative and pre-induction measures. However, after
extubation all parameters returned to preoperative levels,
(Table 2).
Mean operative time was signiﬁcantly longer in patients
of class III compared to those of class I and II withnon-signiﬁcantly longer duration of surgery in patients of
class II compared to those of class I. Moreover, calculated
intraoperative blood loss was signiﬁcantly less in patients
of class I compared to other classes with non-signiﬁcantly
more blood loss in patients of class III compared to those
of class II. Consequently, more patients in class III
(66.7%) required blood transfusion compared to both class
I (26.7%) and II (50%) with signiﬁcantly higher number
of patients required blood transfusion in class II compared
to patients of class I. However, number of transfused bags
showed non-signiﬁcant difference among studied patients,
but in favor of class I (Table 3 and Fig. 1).
All recovery times showed BMI-dependence as all were
signiﬁcantly prolonged in patients of class II and III com-
pared to those of class I. Moreover, awakening and extuba-
tion times were signiﬁcantly shorter, but PACU arrival and
orientation times were non-signiﬁcantly shorter in patients
Table 3 Operative data.
Class I Class II Class III Statistical signiﬁcance
Operative time (min) 116.5 ± 20.9 (90–160) 119.7 ± 19.6 (100–180) 149.2 ± 30 (110–210) Z= 1.063, p1 > 0.05
Z= 2.161, p2 = 0.031
Z= 2.125, p3 = 0.034
Intraoperative blood loss (ml) 474.9 ± 95.3 (332–753) 518.9 ± 86.2 (406–730) 597 ± 90.1 (494–751) Z= 2.275, p1 = 0.023
Z= 3.237, p2 = 0.001
Z= 1.883, p3 > 0.05
Blood transfusion data
Number required 8 (26.7%) 9 (50%) 8 (66.7%) X2 = 6.306, p1 = 0.016
X2 = 17,216, p2 = 0.005
X2 = 3.061, p3 = 0.043
Number of units 1.3 ± 0.5 (1–2) 1.4 ± 0.5 (1–2) 1.6 ± 0.7 (1–3) Z= 0.414, p1 > 0.05
Z= 1.134, p2 > 0.05
Z= 0.577, p3 > 0.05
Data are presented as mean ± SD and numbers; ranges and percentages are in parenthesis, p> 0.05: non-signiﬁcant difference, p1: signiﬁcance
difference between class I and II, p2: signiﬁcance between class I and III, p3: signiﬁcance between class II and III.
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Figure 1 Mean operative time and blood loss.
198 W. Ahmed Ibrahim, A. Abdalla Mohamedof class II compared to class III patients (Table 4 and
Fig. 2).
All patients passed their 1st PO day at ICU and were dis-
charged on the 2nd morning. During ICU stay, all patients
were maintained on IV ﬂuid therapy and 23 patients (38.3%)
complained of PONV of which 11 patients (47.8%) requested
for antiemetics. Mean time till 1st walk was signiﬁcantly longer
in patients of class III compared to those of class I and II with
non-signiﬁcantly shorter time in patients of class I compared
to patients of class II. Moreover, the frequency of patients
who could walk within 1st 6-h PO was signiﬁcantly higher in
class I compared to those of other classes with non-signiﬁcant
difference in favor of class II. The frequency of patients who
could take their 1st oral intake with 24-h PO was signiﬁcantly
higher in class I and II compared to those of class III with non-
signiﬁcant difference between class I and II, but in favor of
class I. However, mean time till 1st oral intake was non-signif-
icantly different between studied classes but was in favor of
class II (Table 5 and Fig. 3).
Sixteen patients (26.7%) developed postoperative complica-
tions; wound infection was the commonest and was reported in
11 patients (18.3%) of them 6 were diabetics and required
intensive insulin therapy for control of diabetes and antibioticand anti-inﬂammatory therapy with frequent wound dressing.
Two patients required operative wound drainage and this
prolonged their hospital stay for 17 and 19 days, respectively.
Three patients had preoperative COPD and those patients
developed respiratory distress and one of them required ICU
admission and mechanical ventilation for 3 days but weaned
successfully without distress. Three patients developed status
asthmaticus and required intensive treatment for attack con-
trol till resolution. One patient developed deep venous throm-
bosis that assured by Doppler examination and were managed
conservatively till complete resolution without getting more
complications. One diabetic patient developed hyperglycemic
hyperosomlar coma and required intensive insulin therapy
and ﬂuid replacement and responded well without sequale.
Unfortunately, one patient had acute myocardial infarction
that failed to respond to conservative treatment and died in
ICU on the 7th postoperative day.
Mean postoperative hospital stay was signiﬁcantly longer in
patients of class III compared to patients of class I (Z= 2.956,
p= 0.003) and II (Z= 2.311, p= 0.021) with signiﬁcantly
(Z= 2.616, p= 0.009) shorter duration of postoperative hos-
pital stay in patients of class II compared to those of class III
(Fig. 4).4. Discussion
The present selective study was designed to include only pa-
tients with BMIP 30 kg/m2 depending on the previous data
that morbidity and mortality rise sharply when the BMI is
>30 kg/m2 [9], however, the current study did not confront
grave problems leading to occurrence of mortalities, this could
be attributed to meticulous patients’ selection and preoperative
adjustment of associated co-morbidities and extended post-
anesthetic care without reliance on ward care physicians. In
support of the possibility of sparing immediate complications
causing mortalities, Demir et al. [10] found that obesity does
not increase short-term mortality for open heart surgery; how-
ever, it increases the risk of postoperative pulmonary and gas-
trointestinal complications and discharge with morbidity
which is signiﬁcantly frequent with increasing BMI.
Table 4 Mean recovery times recorded for studied patients categorized according to BMI.
Class I Class II Class III Statistical signiﬁcance
Awakening time (min) 5.5 ± 1.3 (4–8) 7.1 ± 1.3 (5–9) 7.8 ± 1 (6–9) Z= 2.956, p1 = 0.003
Z= 2.966, p2 = 0.003
Z= 2.355, p3 = 0.019
Extubation time (min) 6.7 ± 0.8 (6–9) 8.1 ± 1.5 (6–11) 9.5 ± 2 (7–12) Z= 2.857, p1 = 0.004
Z= 3.075, p2 = 0.002
Z= 2.716, p3 = 0.007
PACU arrival time (min) 12 ± 0.9 (10–14) 14 ± 1.8 (11–17) 15 ± 2 (12–18) Z= 2.726, p1 = 0.006
Z= 2.974, p2 = 0.003
Z= 1.479, p3 > 0.05
Orientation time (min) 13 ± 1.3 (11–16) 16 ± 1.7 (13–19) 17 ± 2.6 (13–20) Z= 3.421, p1 = 0.001
Z= 2.764, p2 = 0.006
Z= 1.266, p3 > 0.05
Data are presented as mean ± SD; ranges are in parenthesis, p> 0.05: non-signiﬁcant difference, p1: signiﬁcance difference between class I and
II, p2: signiﬁcance between class I and III, p3: signiﬁcance between class II and III,
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Figure 2 Mean recovery times of patient of the three classes.
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of anesthesia using a bolus of remifentanil and maintenance
of anesthesia using continuous remifentanil infusion at rate
of 14 lg/kg/h and balanced sevoﬂurane anesthesia at 1.24%Table 5 Postoperative data.
Data Class I Class II
Time till 1st walk (hours)
Frequency
<6 h 10 (33.3%) 3 (16.7%)
6–12 h 16 (56.7) 14 (77.7%)
>12 h 3 (10%) 1 (5.6%)
Mean 7.6 ± 3.5(4–16) 8.5 ± 2.9(4–15)
Time till 1st oral intake (hours)
Frequency
624 h 18 (60%) 9 (50%)
>24–36 h 10 (33.3%) 6 (33.3%)
>36 h 2 (6.7%) 3 (16.7%)
Mean 24.2 ± 9.9 (12–48) 27.7 ± 10.2 (16–
Data are presented as mean ± SD and numbers; ranges and percentages a
difference between class I and II, p2: signiﬁcance between class I and III,end-tidal volume. Such anesthetic procedure was previously
documented by van Delden et al. [11] as the best combination
that achieved the optimal balance between the quality, and
recovery from anesthesia and by Paventi et al. [12] who re-
ported that remifentanil infusion facilitates awakening times
from balanced anesthesia with sevoﬂurane in obese patients,
submitted to laparoscopic cholecystectomy.
The reported hypotensive effect of induction and mainte-
nance of anesthesia depending on remifentanil signiﬁcantly de-
creased arterial pressures and HR compared both to
preoperative and pre-induction measures, which allowed con-
trol on operative bleeding, but the decrease did not compro-
mise tissue perfusions or lead to episodes of desaturation.
Short duration of action of both remifentanil and sevoﬂurane
allowed return of all parameters to preoperative levels and
provided easy and rapid recovery despite the ﬁnding that all
recovery times showed BMI-dependence as all were signiﬁ-
cantly prolonged in patients of class II and III compared to
those of class I with signiﬁcantly shorter awakening and extu-
bation times in patients of class II compared in patients of
class III patients.Class III Statistical signiﬁcance
2 (16.7%) X2 = 6.231, p1 = 0.013
9 (75%) X2 = 3.695, p2 = 0.039
1 (8.3%) X2 = 0.475, p3 > 0.05
9.5 ± 2.5(6–15) Z= 1.236, p1 > 0.05
Z= 3.095, p2 = 0.002
Z= 0.775, p3 = 0.019
4 (33.3%) X2 = 7.656, p1 = 0.010
7 (58.4%) X2 = 7.183, p2 = 0.01
1 (8.3%) X2 = 1.183, p3 > 0.05
48) 28 ± 9.2 (15–48) Z= 1.092, p1 > 0.05
Z= 1.512, p2 > 0.05
Z= 0.306, p3 > 0.05
re in parenthesis, p> 0.05: non-signiﬁcant difference, p1: signiﬁcance
p3: signiﬁcance between class II and III.
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200 W. Ahmed Ibrahim, A. Abdalla MohamedIn line with the appropriateness of the applied anesthetic
regimen for such patients’ population; Bidgoli et al. [13] com-
pared effects of sufentanil and remifentanil on the quality of
recovery in morbidly obese patients undergoing laparoscopic
gastroplasty and found that with remifentanil time to extuba-
tion was signiﬁcantly shorter and quality of recovery and dura-
tion of post-anesthesia care unit stay were comparable with
statistical difference between groups. Also, Niwa et al. [14]
using similar protocol of remifentanil, propofol and rocuroni-
um for induction and anesthesia was maintained with sevoﬂu-
rane and remifentanil for anesthetizing a morbid obese patient
assigned for surgery in prone position and documented that
after turning to prone position, severe physiological abnormal
signs were not recognized and concluded that these anesthetic
agents were administrated appropriately for morbid obesity.
In support of the effect of obesity on recovery times, Jaoua
et al. [15] using propofol/remifentanil infusion for induction
and maintenance of anesthesia during laparoscopic surgery
for obesity reported hemodynamic stability in 79% of patients
at induction and in patients who had BMI < 49 kg/m2 showed
signiﬁcantly fast time extubation than those who had
BMI > 49 kg/m2. Moreover, Diepstraten et al. [16] reported
that compared with lean body weight and ideal body weight,total body weight proved to be the most predictive covariate
for propofol clearance and as a result, it is anticipated that
dosage of propofol for maintenance of anesthesia in morbidly
obese children and adolescents should be based on TBW using
an allometric function.
The impact of obesity on surgical outcome was manifested
as signiﬁcantly prolonged mean operative time in patients of
class III compared to those of class I and II. Also, calculated
amount of intraoperative blood loss, frequency of need for
transfusion were signiﬁcantly less in patients of class I com-
pared to other classes with non-signiﬁcantly fewer number of
transfused units. Moreover, patients of class I showed signiﬁ-
cantly shorter duration till 1st ambulation and oral intake with
signiﬁcantly shorter duration of postoperative hospital stay
compared to other groups.
These data are in hand with that previously reported in lit-
erature; Murphy et al. [17] found both anesthesia and opera-
tive times were modestly increased in obese women versus
non-obese women undergoing second-trimester surgical termi-
nation, and for patients at advanced gestational age with prior
cesarean delivery, clinicians should be aware of the potential
increase in complications as well as increased operative time
in obese women, and counsel appropriately. Gadinsky et al.
[18] reported that comparing normal weight to obese class
III, time differences were signiﬁcant in total room time, sur-
gery time, tourniquet time and closure time and so BMI can
be used to better allocate operating room time for total knee
arthroplasty. Choi et al. [19] found morbidly obese patients
who undergo coronary artery bypass grafting had longer oper-
ating times, intensive care unit stays and postoperative hospital
stays than the non-morbidly obese patients and these patients
require considerably more resource utilization in the operating
room and intensive care unit. Akbayir et al. [20] documented
that endometrial cancer patients with a BMI of P30 had sig-
niﬁcantly longer operating time.
Postoperative complications occurred in 16 patients with
wound infection was the commonest and occurred in 11 pa-
tients, chest morbidities occurred in 6 patients and one had
diabetic coma, another had acute myocardial infarction and
the 16th had deep vein thrombosis. This ﬁgure coincided with
Elgafy et al. [21] who previously reported that after surgery,
obese patients are at higher risk for wound infection and
deep vein thrombosis and with Nilsson et al. [22] obesity is
an important risk factor for development of wound infection
and wound healing complications and a modest increase in
postoperative relative weight gain during the ﬁrst postopera-
tive day seemed to increase the risk of postoperative compli-
cations in women undergoing abdominal hysterectomy.
The obtained results and review of literature allowed con-
cluding that obesity showed deleterious anesthetic and surgical
effects with prolonged operative and recovery times and more
need for blood transfusion, ICU admission and prolonged hos-
pital stay duration. The used anesthetic regimen allowed con-
trolled hypotension without compromising patients’ general
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